Breaking News
FONT-SIZE Plus   Neg
Share SHARE

J.C. Penny Begins Business Revamp Process - Update

RELATED NEWS
Trade JCP now with 

J. C. Penney Co. Inc. (JCP: Quote) said Thursday it has started the simplification process of its business, in line with a revamp plan revealed last January that would enable it better compete with rivals.

As a first step, J.C. Penney is reorganizing the workforce at its headquarters in Plano, Texas, with plans to close its customer call center in Pittsburgh, Pennsylvania.

The company will adopt a new approach to pricing, promotion, merchandising, blended with a management structure that has fewer layers, wider control and more accountability.

J. C. Penny CEO Ron Johnson said the company will henceforth work like a start up and will adopt a management style based on leadership.

"We are going to operate like a start-up. We are going to extend the reach and span of control of our very best talent...," Johnson said.

Last January, J.C. Penney revealed plans to cut annual costs by $900 million by 2013. The company plans to cut costs to below 30 percent of sales by 2013 and enable an expense run rate of 27 percent by 2015.

Johnson had revealed that store experience will be enhanced by including Main Street - the entire store merchandised in a series of 80 to 100 brand shops. J. C. Penney expects to feature 30 new and transformed brands by the fall of 2012. It will also sport a new logo.

Johnson took over as CEO of J. C. Penny in mid-June 2011 at a time when the company was struggling along with long-time rival Sears Holdings Inc. (SHLD) that has planned the sale of a number of unviable stores.

J.C. Penney in February reported a quarterly loss of $87 million or $0.41 per share, compared to net income of $271 million or $1.13 per share last year. Sales for the quarter slid 4.9 percent to $5.43 billion from last year.

JCP is trading on the NYSE at $35.20, down $0.26 or 0.73%, on a volume of 1.6 million shares.

Register
To receive FREE breaking news email alerts for J. C. Penney Company, Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.